Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide developed as an analog of the naturally occurring immunopeptide tuftsin, with modifications that extend its stability and pharmacological activity. It has been studied extensively in research settings for its observed effects on GABAergic neurotransmission, anxiety-related behavior, and cognitive performance in preclinical models.

Preclinical research has examined Selank’s ability to modulate GABA-A receptor activity, an interaction thought to underlie its anxiolytic-like effects in animal behavioral studies. Studies have also investigated its influence on the expression of brain-derived neurotrophic factor (BDNF) and its effects on memory consolidation and retrieval in rodent models. In immunological research, Selank has been studied for its effects on interleukin expression and T-cell function, reflecting its tuftsin-derived immunomodulatory properties.

Selank is a commonly referenced compound in research examining peptide-based anxiolytic mechanisms, nootropic peptide pharmacology, and neuroimmunology. Its dual focus on neurological and immune pathways makes it a compound of interest across multiple research disciplines. This 5mg lyophilized preparation is intended for in vitro and preclinical research use.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.